COA with every orderTracked worldwide shippingDispatch Mon–SatFor research use only

Shop

Showing 113–120 of 120 results

  • Vesilute 20mg

    Vesilute 20mg

    20mgHPLC99.287%
    $130

    Vesilute is a synthetic bioactive peptide belonging to the Havensone peptide family, featuring a core amino acid sequence of Glu-Asp. It exerts regulatory effects on urinary system tissues like the bladder and prostate by influencing cellular gene expression to modulate physiological functions in these tissues.

    View COA (Certificate of Analysis)

  • Vesugen 20mg

    Vesugen 20mg

    20mgHPLC99.291%
    $125

    Vesugen is a synthetic peptide composed of a specific amino acid sequence, which has the function of regulating various physiological processes in organisms. It exerts its biological effects by binding to specific targets within cells, influencing gene expression and cellular metabolism.

    View COA (Certificate of Analysis)

  • Vilon 20mg

    Vilon 20mg

    20mgHPLC99.630%
    $130

    Vilon, a dipeptide composed of lysine and glutamic acid, exhibits multifaceted effects. In anti-aging, it delays cellular aging by improving gastrointestinal function, enhancing enzyme activity, and promoting nutrient absorption. It also boosts collagen expression in the skin to reduce signs of aging. In tissue repair and regeneration, Vilon supports stem cell activation and proliferation, accelerates wound healing, and aids in tissue repair (e.g., skin and intestinal tissues) by regulating fibroblast activity. Beneficial for cardiovascular and renal health, it improves cardiovascular function and regulates microvascular permeability in renal diseases. Additionally, Vilon shows potential applications in adjuvant therapy for liver diseases, diabetes, and radiation injuries, as well as in regulating overall bodily functions.

    View COA (Certificate of Analysis)

  • VIP 10mg

    VIP 10mg

    10mgHPLC99.291%
    $175

    VIP (Vasoactive Intestinal Peptide) is an acidic polypeptide neurotransmitter composed of 28 amino acid residues, belonging to the vasoactive intestinal peptide/glucagon-like peptide family. Primarily synthesized and secreted by the central nervous system, gastrointestinal ganglia, and immune cells, it diffuses to target cells via blood or interstitial fluid. By binding to specific receptors, it exerts physiological effects crucial for vascular regulation, gastrointestinal function control, immune homeostasis, and neuroprotection.

    View COA (Certificate of Analysis)

  • VIP 6mg

    VIP 6mg

    6mgHPLC99.827%
    $130

    VIP (Vasoactive Intestinal Peptide) is an acidic polypeptide neurotransmitter composed of 28 amino acid residues, belonging to the vasoactive intestinal peptide/glucagon-like peptide family. Primarily synthesized and secreted by the central nervous system, gastrointestinal ganglia, and immune cells, it diffuses to target cells via blood or interstitial fluid. By binding to specific receptors, it exerts physiological effects crucial for vascular regulation, gastrointestinal function control, immune homeostasis, and neuroprotection.

    View COA (Certificate of Analysis)

  • Retatrutide 5mg

    Retatrutide 5mg

    5mgHPLC99.612%
    $43

    Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.

    View COA (Certificate of Analysis)

  • Retatrutide 15mg

    Retatrutide 15mg

    15mgHPLC99.427%
    $84

    Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.

    View COA (Certificate of Analysis)

  • Retatrutide 60mg

    Retatrutide 60mg

    60mgHPLC99.543%
    $253

    Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.

    View COA (Certificate of Analysis)

WhatsApp us